Similarly, Beclin1, which showed no major changes in total lysates (Figure 5C), also showed a solubility shift in AD brains, being depleted from the RIPA-soluble fraction and enriched in the RIPA-insoluble fraction (Figure 5I–K). This evidence concerns the gene BECN1 and Alzheimer disease.